Oncology & Cancer

Palbociclib efficacious in metastatic breast cancer

(HealthDay)—Palbociclib can help slow the progression of advanced breast cancer, according to a study published in the Nov. 17 issue of the New England Journal of Medicine.

HIV & AIDS

HIV patients ‘aging before their time’

While combination antiretroviral therapy has meant that people with HIV can live longer lives, research shows that the virus makes fundamental changes to the immune system by increasing the risk of developing age-related ...

Oncology & Cancer

Acquired resistance to combination drug treatment in cancer

A team of scientists led by Dr Bhaskar Bhattacharya and Associate Professor Richie Soong from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) conducted a study on acquired ...

Oncology & Cancer

More chemo drugs don't improve treatment of rare bone cancer

Osteosarcoma patients with tumors that haven't responded well to the standard chemotherapy regimen have unimproved outcomes and more side effects when given two additional drugs, a large international trial has found.

Diabetes

Which diabetes drug is best?

(HealthDay)—No single drug to treat type 2 diabetes stands out from the pack when it comes to reducing the risks of heart disease, stroke or premature death, a new research review finds.

Diseases, Conditions, Syndromes

Doubling up to fight pain

Queen's University researcher Ian Gilron has uncovered a more effective way of treating fibromyalgia, a medical condition characterized by chronic widespread pain typically accompanied by fatigue, as well as sleep, mood and ...

Medications

FDA approves first pill to treat all forms of hepatitis C

Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.

page 15 from 33